IL6 and Insulin resistance: The differences in the laboratory findings between the two groups included BUN, ALT, absolute lymphocyte count, neutrophil to lymphocyte ratio, triglycerides, inflammation markers (CRP, D-dimer and IL-6) and the percent of patients who suffered from ARDS, cytokine storm and insulin resistance, which was higher in the non-surviving group.